J1729 Hydroxyprogesterone Caproate - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Hydroxyprogesterone Caproate

Brand Name:

Hydroxyprogesterone Caproate

Strength:

10 mg

HCPCS:

J1729

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

Progestin

Minor Drug Class:

Oral (Y/N):

No

FDA Approval Year:

2011

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2018

CMS Discontinuation Date:

Status:

In Use